EUROIMMUN Medizinische Labordiagnostika AG
Recent events
Recent events tied to this brand in public sources.
Back to profile1 entries
2020
EUROIMMUN launches quantitative SARS-CoV-2 antibody test
EUROIMMUN launched the Anti-SARS-CoV-2 QuantiVac ELISA (IgG), a quantitative test to measure IgG antibodies against the SARS-CoV-2 S1 antigen. The assay is available in countries accepting the CE mark; the company planned to seek U.S. FDA Emergency Use Authorization.